Literature DB >> 7007743

Hypertension after coronary operation. Can it be prevented by pulsatile perfusion?

T A Salerno, M Henderson, F M Keith, E J Charrette.   

Abstract

Nonpulsatile perfusion during cardiopulmonary bypass (CPB) has been implicated as a causative factor of postoperative hypertension. In a consecutive series, patients undergoing coronary bypass were selected for perfusion with either nonpulsatile flow (American Optical roller pump) or pulsatile flow (Desjardin's modification of the roller pump). The incidence of postoperative hypertension and the levels of peripheral renin were noted. No differences could be observed in renin activity, with either modality of perfusion, before CPB, after 30 minutes of stable CPB, or 2 hours postoperatively. Hypertension, necessitating treatment, occurred in 60% of the patients having pulsatile and 68% of those having nonpulsatile perfusion (p less than 0.05). Although pulsatile CPB would appear to be more physiological than nonpulsatile perfusion, this method of creating pulsatile flow does not appear to eliminate postoperative hypertension.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7007743

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

Review 1.  An epidemiologist's review of the case for pulsatile flow during cardiopulmonary bypass.

Authors:  Donald S Likosky
Journal:  J Extra Corpor Technol       Date:  2009-03

2.  Factors relating to the development of hypertension after cardiopulmonary bypass.

Authors:  T J Cooper; T H Clutton-Brock; S N Jones; J Tinker; T Treasure
Journal:  Br Heart J       Date:  1985-07

3.  Hypertension following coronary artery bypass graft.

Authors:  W McIlvaine; M Boulanger; J G Maillé; B Paiement; J Taillefer; P Sahab
Journal:  Can Anaesth Soc J       Date:  1982-05

4.  Role of renin-angiotensin system in cardiopulmonary bypass hypertension.

Authors:  G E Townsend; J E Wynands; D G Whalley; P Wong; D R Bevan
Journal:  Can Anaesth Soc J       Date:  1984-03

5.  Nifedipine for postoperative blood pressure control following coronary artery vein grafts.

Authors:  V S Iyer; W J Russell
Journal:  Ann R Coll Surg Engl       Date:  1986-03       Impact factor: 1.891

Review 6.  Isradipine. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of mild to moderate hypertension.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.